CT26-hPD-L1

Export PDF

Strain Information

Cell Line

CT26-Cd274em1(hPDL1)/Smoc

Cat. NO.

NM-S24A-TM01

Model Description

The endogenous mouse Cd274(also known as  PD-L1)  gene was replaced by human CD274 gene. 

Strain State

Validation of tumorigenic capacity completed

Validation Data

image.png

Figure 1. hPDL1 expression in wild-type CT26 and CT26-hPDL1 cell lines.

image.png


Figure 2. Tumor growth curve of CT26-hPDL1 syngeneic model (n=3).

image.png


Figure 3. The expression of hPDL1 in humanized modified tumors by FACS.

Related Strain(s)

MC38-hPD-L1/hCLAUDIN 18.2
Cell Line：

MC38-hPD-L1/hCLAUDIN 18.2

Cat. NO.：NMC-230113
CT26-hPD-L1/hCLAUDIN 18.2
Cell Line：

CT26-hPD-L1/hCLAUDIN 18.2

Cat. NO.：NMC-230112
3T3-L1-Hif3a-KO
Cell Line：

3T3-L1-Hif3a-KO

Cat. NO.：NMC-230111
CT26-hIL13RA2
Cell Line：

CT26-hIL13RA2

Cat. NO.：NM-S24A-TM30
B16F10-hPDL1-Sirpa-KO
Cell Line：B16F10-hPDL1-Sirpa-KO
Cat. NO.：NMC-230067

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more